A recent study also reported that the immunogenicity of genetically-modified oncolytic vaccinia virus expressing the mimotope of disialoganglioside (GD2), a neuroblastoma-associated antigen, could be improved by the co-expression of the mimotope of GD2 together with HP-NAP [66]. Here, CTNNBL1 is linked to neuroblastoma.